Orlando, Florida
Phase 1 cancer trials in Orlando, FL
41 Phase 1 cancer studies are recruiting participants at sites in Orlando as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Orlando at a glance
- 41 studies are recruiting at a site in Orlando.
- By phase: Phase 1 (21), Phase 1/2 (20).
- By sponsor: industry (39), university, hospital or other (2).
- By research area: Lung Cancer (18), Breast Cancer (16), Lymphoma (4), Prostate Cancer (2), Pancreatic Cancer (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Orlando
Basic details from each study's public record (the 30 most recently updated of 41). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Advent Health Medical Group Radiation Oncology at Central Florida
- Registry record
- NCT07020117 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Study site
- Sarah Cannon Research Institute at Florida Cancer Specialists
- Registry record
- NCT06638307 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- AdventHealth Cancer Institute
- Registry record
- NCT06586957 · updated
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Compass Therapeutics
- Study site
- Florida Cancer Specialists - Lake Nona
- Registry record
- NCT06150664 · updated
Study of XB010 in Subjects With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Study site
- Sarah Cannon Research Institute at Florida Cancer Specialists
- Registry record
- NCT06545331 · updated
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Terremoto Biosciences Inc.
- Study site
- Florida Cancer Specialists - Lake Nona
- Registry record
- NCT07109726 · updated
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sutro Biopharma, Inc.
- Study site
- SCRI at Florida Cancer Specialists
- Registry record
- NCT07807345 · updated
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Sarah Cannon Research Institute - Lake Nona Florida
- Registry record
- NCT06293898 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- Advent Health
- Registry record
- NCT04585750 · updated
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Sara Cannon Research Institute Lake Nona
- Registry record
- NCT05983432 · updated
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT06998407 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Orlando, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Orlando
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Sarah Cannon Research Institute at Florida Cancer Specialists
- Registry record
- NCT07277413 · updated
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona
- Registry record
- NCT06914128 · updated
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Orlando Health Cancer Institute ( Site 0108)
- Registry record
- NCT07227597 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Sarah Cancer Research Institution - Florida Cancer Specialist
- Registry record
- NCT06706076 · updated
SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Florida Cancer Specialists Lake Nona
- Registry record
- NCT07857616 · updated
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Obsidian Therapeutics, Inc.
- Study sites
- Advent Health Orlando · Orlando Health Cancer Institute (Melanoma/NSCLC)
- Registry record
- NCT06060613 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- DualityBio Inc.
- Registry record
- NCT05914116 · updated
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT07038343 · updated
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Orlando Health Ambulatory Care Center · Orlando Health Cancer Institute · Orlando Health Orlando Regional Medical Center
- Registry record
- NCT07227298 · updated
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- Advent Health Orlando
- Registry record
- NCT06362252 · updated
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pierre Fabre Medicament
- Study site
- Sarah Cannon Research Institute - Florida Cancer Specialists
- Registry record
- NCT04913285 · updated
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Sarah Cannon Research Institute at Florida Cancer Specialists
- Registry record
- NCT05245500 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Orlando, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Genentech, Inc.
- Study site
- Sarah Cannon Research Institute @ Florida Cancer
- Registry record
- NCT05800665 · updated
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- AstraZeneca
- Registry record
- NCT07192614 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Orlando, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Orlando
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Arnold Palmer Hospital for Children · Nemours Children's Hospital
- Registry record
- NCT04726241 · updated
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment
- Phase 1
- Ages 18 to 80
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Orlando Clinical Research Center
- Registry record
- NCT07853040 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Study site
- Arnold Palmer Hospital for Children
- Registry record
- NCT05848687 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Orlando, FL on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Orlando
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- Florida Cancer Specialists
- Registry record
- NCT07186842 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Orlando, FL on ClinicalTrials.gov.
Ask about studies near Orlando
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
240 studies recruiting across 42 cities.
Tampa
74 studies recruiting.
Jacksonville
47 studies recruiting.
Miami
47 studies recruiting.
Sarasota
45 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections